Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Lorcaserin for Weight Loss in Schizophrenia
NCT02796144Phase 4Terminated
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Sep 2016
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lorcaserin, metformin in Overweight, sponsored by University of North Carolina at Chapel Hill. Started Sep 2016; status: terminated.
02
Drugs
lorcaserinmetformin
03
Conditions
Overweight
Beyond the preview
Go deeper on NCT02796144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02796144.